Primed for Acceleration

Local Infusion is improving care for chronic autoimmune patients thorough a community-based model improving outcomes, expanding access and lowering costs
Published:
April 2026
THE PROBLEM
Patients face long wait times, limited scheduling flexibility

Infusion therapy has become increasingly inconvenient, expensive, and inefficient. Patients face long wait times, limited scheduling flexibility, and uncomfortable hospital settings.

At the same time:

  • Health plans are laser focused on managing the rapidly escalating total cost of care and struggling to provide access in suburban and rural markets where hospitals are limited or over capacity.
  • Health systems are losing patients and 340B eligible services as payers steer infusions to lower-cost sites of care.
  • Patients want greater choice, flexibility, and comfort; 51% say convenience and access are the top factors in their decision-making (NRC Health).

The current, typical care delivery model no longer serves the needs of patients, health plans or health systems.

THE MARKET

Specialty infusion utilization is rising rapidly, and a growing pipeline of drugs is putting real strain on every major stakeholder in the system.

Several trends shape this market:

  • Payer/employer cost pressure: Payers are increasingly steering appropriate patients toward ambulatory and office-based infusion centers.
  • Access gaps: Payers are seeking more convenient access for members, and solutions that increase member satisfaction, provider satisfaction and referral loyalty, and employer perception of the plan’s specialty capabilities.
  • Market share risk: Many health systems lack the infrastructure to compete with nimble, tech-enabled infusion entrants, risking loss of patients, specialist referrals, and specialty service lines.

The result is a system stuck in tension: rising demand, rising costs, and misaligned incentives that prevent meaningful change. The demand for convenient, tech-enabled, and system-aligned infusion solutions has never been greater.

WHY WE INVESTED

Local Infusion’s care model uniquely aligns incentives across health plans, health systems, and employers.

It lowers total cost for payers and employers, preserves $340B economics for health systems, and keeps patients at the center of every decision.

Local Infusion has scaled from zero to 40 locations across eight states in just three years, each with private suites, flexible hours (including evenings and weekends), and patient-focused amenities. Each patient is supported by a Dedicated Infusion Guide who oversees onboarding, insurance verification, and post-treatment follow-up. They also maintain tight feedback loops with providers and regular reporting to health plans, including volume by site of care, savings vs. baseline, therapy adherence/persistency, and experience metrics.

  • Patient NPS: 98 (vs. healthcare average of 58)
  • Referring provider NPS: 94
  • Revenue collection rate: 99%+

Their AI-powered Infusion Guide model has produced industry-leading patient and referring physician satisfaction, while also enabling a structurally lower cost base than competitors. That efficiency allows Local Infusion to reinvest in access and capacity—serving tertiary and rural markets that many traditional providers avoid.

The result is a true win-win-win-win: better outcomes for patients, lower costs for payers and employers, and sustainable economics for health systems.

More at mylocalinfusion.com.

More  Insights

'